Toggle navigation
Home
Search
Services
Blog
Contact
About
Assay Development and Initial Pharmacology Studies with SMA-491
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
mitoNEET as a therapeutic target for TBI
Alzheimer's Disease Research Center
Heparan Sulfate Receptors for HSV-1 and HSV-2
Molecular Genetics of Leukocyte Adhesion Molecules
Support Participation in International Scientific Meetings by U.S. Astronomers
Recently added grants:
Risk Stratified Enhancements to Clinical Care: Targeting Care for Patients Identified Through Predictive Modeling as Being at High Risk for Suicide, with the Office of Mental Health Operations
AIDS Clinical Trials Group for Research on Therapeutics for HIV and Related Infections
AIDS Clinical Trial Group Laboratory Center
A phase 0 pilot study to determine if papaverine increases oxygenation in spontaneous canine soft tissue sarcoma
Optimization and Validation of an indicator cell assay for blood-based diagnosis of lung cancer
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CM52207-10-0-2
Application #
7571114
Study Section
Project Start
2004-12-15
Project End
2009-12-14
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 CA
Preclinical Pharmacological Studies of Antitumor and Other Therapeutic Agents
/ University of Alabama Birmingham
$244,166
NIH 2007
N01 CA
Preclinical Pharmacological Studies of Antitumor and Other Therapeutic Agents
Hill, Donald /
$233,463
NIH 2007
N01 CA
Preclinical Pharmacological Studies of Antitumor and Other Therapeutic Agents
/
NIH 2007
N01 CA
Assay Development and Initial Pharmacology Studies with SMA-491
/
NIH 2007
N01 CA
/
Comments
Be the first to comment on this grant